Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on ... MarketWatch (press release) "Two-year results from the PLATINUM Workhorse clinical trial will provide important follow-up data on our next-generation PROMUS Element(TM) Everolimus-Eluting Platinum Chromium Stent," said Keith D. Dawkins, MD, Global Chief Medical Officer for Boston ... |
